Envestnet Asset Management Inc. Sells 58,607 Shares of Unilever PLC $UL

Envestnet Asset Management Inc. trimmed its holdings in Unilever PLC (NYSE:UL) by 1.5% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 3,867,284 shares of the company’s stock after selling 58,607 shares during the quarter. Envestnet Asset Management Inc. owned 0.16% of Unilever worth $236,562,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. Wellington Management Group LLP lifted its holdings in shares of Unilever by 13.9% in the 1st quarter. Wellington Management Group LLP now owns 28,100,442 shares of the company’s stock worth $1,673,381,000 after acquiring an additional 3,421,054 shares during the last quarter. Raymond James Financial Inc. lifted its holdings in shares of Unilever by 7.1% in the 1st quarter. Raymond James Financial Inc. now owns 3,340,231 shares of the company’s stock worth $198,911,000 after acquiring an additional 221,958 shares during the last quarter. Hamlin Capital Management LLC lifted its holdings in shares of Unilever by 0.5% in the 2nd quarter. Hamlin Capital Management LLC now owns 3,085,571 shares of the company’s stock worth $188,744,000 after acquiring an additional 14,711 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of Unilever by 4.3% in the 1st quarter. Northern Trust Corp now owns 2,260,133 shares of the company’s stock worth $134,591,000 after acquiring an additional 93,677 shares during the last quarter. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lifted its holdings in shares of Unilever by 12.8% in the 2nd quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 1,219,261 shares of the company’s stock worth $74,582,000 after acquiring an additional 138,646 shares during the last quarter. 9.67% of the stock is currently owned by institutional investors.

Unilever Trading Up 0.0%

Shares of Unilever stock opened at $62.69 on Tuesday. The firm’s 50-day moving average is $61.65 and its 200 day moving average is $61.85. Unilever PLC has a 1 year low of $54.32 and a 1 year high of $65.66.

Unilever Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 7th will be paid a dividend of $0.5258 per share. The ex-dividend date is Friday, November 7th. This represents a $2.10 annualized dividend and a yield of 3.4%. This is an increase from Unilever’s previous quarterly dividend of $0.52.

Analyst Ratings Changes

Several research analysts recently commented on UL shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Unilever in a research note on Wednesday, October 8th. Jefferies Financial Group reaffirmed an “underperform” rating on shares of Unilever in a research note on Sunday, August 3rd. CICC Research started coverage on shares of Unilever in a research note on Thursday, August 21st. They issued an “outperform” rating on the stock. Finally, Zacks Research downgraded shares of Unilever from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 16th. Two analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Unilever currently has an average rating of “Moderate Buy” and an average price target of $73.00.

Unilever Company Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.